Medtronic Stock Jumps Above $100 After Q2 FY26 Beat and Raised Outlook on 18 November 2025
Medtronic shares jumped 4–5% to around $100–101 late Tuesday morning, hitting a three-year high after the company beat fiscal Q2 2026 earnings and revenue forecasts and raised its full-year outlook. Revenue rose 6.6% to $9.0 billion, with adjusted EPS of $1.36 topping analyst estimates. The rally pushed Medtronic’s market cap to about $129 billion. Demand for heart and diabetes devices drove the gains.